234 related articles for article (PubMed ID: 9805244)
21. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
[TBL] [Abstract][Full Text] [Related]
22. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract][Full Text] [Related]
23. Germ cell tumours of childhood. Report of 170 cases including 59 pure and partial yolk-sac tumours.
Harms D; Jänig U
Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):223-39. PubMed ID: 2424170
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity in alkaline phosphatase isozyme expression in human testicular germ cell tumours: An enzyme-/immunohistochemical and molecular analysis.
Roelofs H; Manes T; Janszen T; Millán JL; Oosterhuis JW; Looijenga LH
J Pathol; 1999 Oct; 189(2):236-44. PubMed ID: 10547581
[TBL] [Abstract][Full Text] [Related]
25. Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin.
Wegman SJ; Parwani AV; Zynger DL
Hum Pathol; 2019 Feb; 84():254-261. PubMed ID: 30359635
[TBL] [Abstract][Full Text] [Related]
26. Residual retroperitoneal tumour tissue in patients treated for metastatic non-seminomatous testicular germ cell tumours: an immunohistochemical investigation.
Jacobsen GK; Olsen J
Tumour Biol; 1985; 6(1):25-35. PubMed ID: 2410971
[TBL] [Abstract][Full Text] [Related]
27. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
Oz Atalay F; Aytac Vuruskan B; Vuruskan H
J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
[TBL] [Abstract][Full Text] [Related]
28. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.
Lau SK; Weiss LM; Chu PG
Mod Pathol; 2007 Mar; 20(3):320-5. PubMed ID: 17277761
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors.
Kamoshida S; Satoh Y; Yasuda M; Kajiwara H; Tsukinoki K; Osamura RY
Oncol Rep; 2002; 9(4):845-51. PubMed ID: 12066220
[TBL] [Abstract][Full Text] [Related]
30. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours.
Marks A; Sutherland DR; Bailey D; Iglesias J; Law J; Lei M; Yeger H; Banerjee D; Baumal R
Br J Cancer; 1999 May; 80(3-4):569-78. PubMed ID: 10408868
[TBL] [Abstract][Full Text] [Related]
31. Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors.
Masiuk M; Lewandowska M; Teresinski L; Dobak E; Urasinska E
Folia Histochem Cytobiol; 2019; 57(3):139-145. PubMed ID: 31513277
[TBL] [Abstract][Full Text] [Related]
32. Glycolipids of human primary testicular germ cell tumours.
Olie RA; Fenderson B; Daley K; Oosterhuis JW; Murphy J; Looijenga LH
Br J Cancer; 1996 Jul; 74(1):133-40. PubMed ID: 8679447
[TBL] [Abstract][Full Text] [Related]
33. Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.
Yamamoto H; Rudén U; Esposti P; Hirano K; Stigbrand T; Andersson L; Hisazumi H; Wahren B
Urol Res; 1988; 16(1):31-6. PubMed ID: 2449757
[TBL] [Abstract][Full Text] [Related]
34. High-throughput microRNAome analysis in human germ cell tumours.
Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
[TBL] [Abstract][Full Text] [Related]
35. Placental-like alkaline phosphatase and DNA flow cytometry in spermatocytic seminoma.
Dekker I; Rozeboom T; Delemarre J; Dam A; Oosterhuis JW
Cancer; 1992 Feb; 69(4):993-6. PubMed ID: 1310437
[TBL] [Abstract][Full Text] [Related]
36. Patterns of seminoma tissue markers and deletions.
Yamamoto H; Rudén U; Ljungdahl-Ståhle E; Brehmer-Andersson E; Hirano K; Hisazumi H; Stigbrand T; Wahren B
Int J Cancer; 1987 Nov; 40(5):615-9. PubMed ID: 2445700
[TBL] [Abstract][Full Text] [Related]
37. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2.
Howitt BE; Brooks JD; Jones S; Higgins JP
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.
Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH
J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738
[TBL] [Abstract][Full Text] [Related]
40. Blood group-related antigens in human germ cell tumors.
Motzer RJ; Reuter VE; Cordon-Cardo C; Bosl GJ
Cancer Res; 1988 Sep; 48(18):5342-7. PubMed ID: 3044584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
